Maltodextrin Urolithin Inclusion Complexes for Aqueous Solubility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Urolithins have poor aqueous solubility, making it challenging to develop effective formulations for their administration, particularly for improving muscle function and other health benefits.

Innovation Solution

The development of aqueous formulations comprising urolithins and maltodextrin, specifically agglomerated maltodextrin, which enhances the solubility and bioavailability of urolithins, allowing for their administration in beverages such as sports drinks.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If urolithins are used in aqueous formulations, then health benefits and muscle function improvement are achieved, but solubility is insufficient leading to poor bioavailability

Engineering Contradiction:
ImprovebioavailabilityVSAvoidsolubility
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent uses maltodextrin as a solubility-enhancing agent that acts as an intermediary between urolithins and water. The maltodextrin forms inclusion complexes with urolithins, where the hydrophobic urolithin molecules are encapsulated within the hydrophilic maltodextrin structure, enabling aqueous solubility while maintaining urolithin stability and bioavailability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite formulation consisting of urolithins combined with maltodextrin. This composite material combines the therapeutic properties of urolithins with the solubility-enhancing properties of maltodextrin, resulting in a formulation that achieves both health benefits and adequate solubility for effective delivery.

Inventive Principle:
Principle #40Composite materials

2Reliability

If urolithins are administered directly, then therapeutic effects are achieved, but poor solubility limits effective delivery

Engineering Contradiction:
Improvetherapeutic effectVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

Maltodextrin serves as a mediator that simplifies formulation by providing a straightforward solubility enhancement mechanism. The inclusion complex formation between maltodextrin and urolithins is a well-established process that does not require complex manufacturing steps, making the formulation easy to manufacture while ensuring reliable therapeutic delivery.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If solubility is enhanced using conventional methods, then aqueous delivery is improved, but bioavailability remains insufficient

Engineering Contradiction:
ImprovesolubilityVSAvoidbioavailability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The maltodextrin inclusion complex acts as a specialized intermediary that simultaneously addresses both solubility and bioavailability. The complex structure protects urolithins from degradation in the gastrointestinal tract while maintaining their molecular integrity for absorption, thereby achieving both high solubility and high bioavailability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the physical state and molecular environment of urolithins by incorporating them into maltodextrin complexes. This parameter change transforms urolithins from poorly soluble crystalline molecules to soluble complexed forms, improving both solubility and bioavailability through modification of physical-chemical parameters.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The maltodextrin-based formulations significantly improve the solubility and bioavailability of urolithins, enabling effective delivery and absorption, thereby enhancing muscle function and overall health benefits.

Implementation Method 1

maltodextrin, for example, agglomerated maltodextrin

Methodology Applied
Scientific EffectMolecular complexation: Adsorption

Data Source

PatentUS20250049750A1Maltodextrin formulations
Publication Date: 2025.02.13 AMAZENTIS SA
  • US20250049750A1 patent drawing
  • US20250049750A1 patent drawing
  • US20250049750A1 patent drawing

AI summary

Disclosed are aqueous formulations comprising urolithins particularly water-based formulations comprising urolithins and maltodextrin. Also disclosed are compositions for admixture with water, methods for the preparation of such aqueous formulations, and to the uses of such formulations for both the treatment of diseases, disorders and conditions, for example, diseases disorders or conditions characterized by inadequate mitochondrial function and for administration to generally healthy individuals for example, for improving health and improving muscle function and performance.